organization · Reporting owner
Thermopylae Holdings Ltd.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AbCellera Biologics Inc.ABCL · Entity 4118 | 10% owner | February 27, 2026 | March 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AbCellera Biologics Inc.
Report date February 27, 2026 · Filed March 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 56,134,097 |
Reported balance
After 2026-02-27 transaction · row 1
1 source rowRow 1 · 2026-02-27 · Purchase · Acquired 38,000 · Balance 56,134,097 F1: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.42 to $3.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.42 to $3.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Mar 2, 2026 19:16 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 38,000 | $3.44 | $130,720.00 |
DisclosureSEC source: 0001834449-26-000004 · wk-form4_1772478998.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,134,097 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.42 to $3.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:20 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 177,457 | $3.27 | $580,284.39 |
DisclosureSEC source: 0001834449-26-000002 · wk-form4_1772227198.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,096,097 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.19 to $3.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2025 Filed Dec 19, 2025 18:24 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | GiftCommon Shares | 225,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001834449-25-000004 · wk-form4_1766168642.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,918,640 F1 · price: This transaction represents a charitable donation of 225,000 common shares the reporting person donated on December 18, 2025. Read SEC document |
| March 11, 2025 Filed Mar 11, 2025 22:42 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 343,631 | $2.16 | $742,242.96 |
DisclosureSEC source: 0001628280-25-012154 · wk-form4_1741732971.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,143,640 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $2.12 to $2.23. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 21:47 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | GiftCommon Shares | 286,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-050097 · wk-form4_1733435235.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,800,009 F1 · price: This transaction represents a charitable donation of 286,000 common shares the reporting person donated on December 4, 2024. Read SEC document |
| August 29, 2024 Filed Aug 29, 2024 20:35 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 283,516 | $2.61 | $739,976.76 |
DisclosureSEC source: 0001628280-24-038829 · wk-form4_1724963720.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,086,009 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $2.55 to $2.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| December 19, 2023 Filed Dec 19, 2023 23:08 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | GiftCommon Shares | 210,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001703057-23-000049 · wk-form4_1703027269.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,802,493 F1 · price: This transaction represents a charitable donation of 210,000 common shares the reporting person donated on December 19, 2023. Read SEC document |
| May 26, 2023 Filed May 26, 2023 18:50 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 153,000 | $6.52 | $997,728.30 |
DisclosureSEC source: 0001209191-23-032481 · doc4.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,012,493 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $6.39 to $6.90. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2022 Filed Dec 20, 2022 15:18 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 85,102 | $10.10 | $859,249.36 |
DisclosureSEC source: 0001209191-22-062090 · doc4.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,859,493 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $10.04 to $10.15. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| October 31, 2022 Filed Nov 10, 2022 00:31 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | GiftCommon Shares | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056271 · doc4.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,774,391 F1 · shares: This transaction represents a chartiable donation of 70,000 common shares the reporting person donated on October 31, 2022. Read SEC document |
| August 19, 2022 Filed Aug 22, 2022 19:27 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 200,000 | $11.46 | $2,292,460.00 |
DisclosureSEC source: 0001209191-22-046998 · doc4.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,844,391 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $11.20 to $11.59. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| June 14, 2022 Filed Jun 15, 2022 17:14 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 9,173 | $8.05 | $73,841.73 |
DisclosureSEC source: 0001209191-22-036884 · doc4.xml · nonDerivative · entry 2 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,644,391 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $8.045 to $8.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 17:14 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 54,915 | $8.03 | $441,066.30 |
DisclosureSEC source: 0001209191-22-036884 · doc4.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,635,218 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $7.99 to $8.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 19:32 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 64,545 | $7.50 | $483,964.86 |
DisclosureSEC source: 0001209191-22-034983 · doc4.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,580,303 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $7.44 to $7.55. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| May 13, 2022 Filed May 17, 2022 19:04 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 300,000 | $7.26 | $2,176,530.00 |
DisclosureSEC source: 0001209191-22-029541 · doc4.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,515,758 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $6.88 to $7.38. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| May 12, 2022 Filed May 16, 2022 18:14 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 1,408,468 | $6.41 | $9,021,800.93 |
DisclosureSEC source: 0001209191-22-029092 · doc4.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,215,758 F1 · shares: The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $5.44 to $6.78. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| December 07, 2021 Filed Feb 3, 2022 23:58 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | GiftCommon Shares | 750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006967 · doc5.xml · nonDerivative · entry 2 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,807,290 F2 · shares: This transaction represents a charitable donation of 750,000 common shares the reporting person donated on December 7, 2021. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 11:05 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | PurchaseCommon Shares | 202,960 | $14.76 | $2,995,912.86 |
DisclosureSEC source: 0001209191-21-064377 · doc4.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,807,290 F1 · shares: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.24 to $15.09. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 21:14 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | SaleCommon Shares | 5,598,420 | $24.03 | $134,530,032.60 |
DisclosureSEC source: 0000899243-21-022994 · doc4.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,604,330 F1 · kind: On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $24.03. F1 · shares: On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $24.03. F1 · price: On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $24.03. Read SEC document |
| May 24, 2021 Filed Feb 3, 2022 23:58 UTC | AbCellera Biologics Inc. ABCL · Entity 4118 | GiftCommon Shares | 1,250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006967 · doc5.xml · nonDerivative · entry 1 Thermopylae Holdings Ltd. · CIK 0001834449 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,557,290 F1 · shares: This transaction represents a charitable donation of 1,250,000 common shares the reporting person donated on May 24, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.